Sacral Nerve-Sparing Piecemeal Spondylectomy for Giant Cell Tumor of Bone in the Sacrum: Surgical Strategy and Accurate Tumor Location Identification.
作者信息
Otsuki Bungo, Sakamoto Akio, Fujibayashi Shunsuke, Shimizu Takayoshi, Murata Koichi, Noguchi Takashi, Matsuda Shuichi
机构信息
Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
出版信息
Spine Surg Relat Res. 2023 Sep 4;8(1):110-113. doi: 10.22603/ssrr.2023-0145. eCollection 2024 Jan 27.
Abstract
摘要
相似文献
1
Sacral Nerve-Sparing Piecemeal Spondylectomy for Giant Cell Tumor of Bone in the Sacrum: Surgical Strategy and Accurate Tumor Location Identification.
Spine Surg Relat Res. 2023 Sep 4;8(1):110-113. doi: 10.22603/ssrr.2023-0145. eCollection 2024 Jan 27.
2
Comparison of the prognostic factors of total en bloc spondylectomy and total piecemeal spondylectomy in patients with Enneking stage III giant cell tumor in the thoracic and lumbar spine.
Eur Spine J. 2023 Jan;32(1):254-260. doi: 10.1007/s00586-022-07455-w. Epub 2022 Nov 16.
3
Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors.
Spine (Phila Pa 1976). 1997 Feb 1;22(3):324-33. doi: 10.1097/00007632-199702010-00018.
4
Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine.
Eur Spine J. 2018 Dec;27(12):3084-3091. doi: 10.1007/s00586-018-5761-3. Epub 2018 Sep 12.
5
Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum.
BMC Musculoskelet Disord. 2021 Dec 6;22(1):1023. doi: 10.1186/s12891-021-04907-0.
6
[Comparison of clinical effects of total spondylectomy with different procedures in treating lumbar metastatic tumor].
Zhongguo Gu Shang. 2014 Sep;27(9):745-51.
7
Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
J Med Case Rep. 2019 Apr 26;13(1):116. doi: 10.1186/s13256-019-2029-4.
8
One-Step Reconstruction with a Novel Suspended, Modular, and 3D-Printed Total Sacral Implant Resection of Sacral Giant Cell Tumor with Preservation of Bilateral S Nerve Roots via a Posterior-Only Approach.
Orthop Surg. 2020 Feb;12(1):58-66. doi: 10.1111/os.12582. Epub 2019 Dec 18.
9
Surgical Strategy for Recurrent Giant Cell Tumor in the Thoracolumbar Spine.
Orthop Surg. 2024 Jan;16(1):78-85. doi: 10.1111/os.13911. Epub 2023 Nov 28.
10
Clinical features and prognostic factors of pediatric spine giant cell tumors: report of 31 clinical cases in a single center.
Spine J. 2019 Jul;19(7):1232-1241. doi: 10.1016/j.spinee.2019.02.011. Epub 2019 Feb 15.
本文引用的文献
1
Multifidus muscle retracted and preserved in resection of malignant bone tumor in the sacral ala.
J Surg Case Rep. 2021 Oct 12;2021(10):rjab439. doi: 10.1093/jscr/rjab439. eCollection 2021 Oct.
2
Efficacy of Intrawound Treatments to Prevent Surgical Site Infection after Spine Surgery: A Systematic Review and Network Meta-analysis.
Pain Physician. 2021 Sep;24(6):E709-E720.
3
Risk factors for the local recurrence of giant cell tumours of the sacrum treated with nerve-sparing surgery.
Bone Joint J. 2020 Oct;102-B(10):1392-1398. doi: 10.1302/0301-620X.102B10.BJJ-2020-0276.R1.
4
Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy.
Bone Joint J. 2020 Feb;102-B(2):177-185. doi: 10.1302/0301-620X.102B2.BJJ-2019-0813.R1.
5
Total spondylectomy for Enneking stage III giant cell tumor of the mobile spine.
Eur Spine J. 2018 Dec;27(12):3084-3091. doi: 10.1007/s00586-018-5761-3. Epub 2018 Sep 12.
6
Decreased rate of surgical site infection after spinal surgery with instrumentation using bundled approach including surveillance and intrawound vancomycin application.
Medicine (Baltimore). 2018 Aug;97(34):e12010. doi: 10.1097/MD.0000000000012010.
7
Recurrence Factors in Giant Cell Tumors of the Spine.
Chin Med J (Engl). 2017 Jul 5;130(13):1557-1563. doi: 10.4103/0366-6999.208239.
8
Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.
Ann Surg Oncol. 2015 Sep;22(9):2860-8. doi: 10.1245/s10434-015-4634-9. Epub 2015 Jun 2.
9
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.
Lancet Oncol. 2010 Mar;11(3):275-80. doi: 10.1016/S1470-2045(10)70010-3. Epub 2010 Feb 10.
10
Outcome of conservative surgery for giant cell tumor of the sacrum.
Spine (Phila Pa 1976). 2009 May 1;34(10):1025-31. doi: 10.1097/BRS.0b013e31819d4127.
Zotero 插件